University Of Texas P Lx Pharma Inc. Transaction History

University Of Texas

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 22, 2023	SELL	$0.12 - $0.3 $7,520 - $18,801	-62,673 Reduced 50.0%	62,673 $8,000
Q3 2022 Nov 10, 2022	BUY	$0.52 - $3.08 $32,589 - $193,032	62,673 Added 100.0%	125,346 $81,000
Q3 2017 Nov 13, 2017	BUY	$6.08 - $7.0 $381,051 - $438,711	62,673	62,673 $403,000

62.7K

Ticker PLXP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 29,137,700
Description
PLx Pharma Inc. operates as a commercial-stage drug delivery platform technology company in the United States. The company's lead product candidates are Vazalore 325 mg for the patients with vascular events, such as heart attacks and clot-related strokes, as well as for use in conditions associated with pain and inflammation, including other asp...

Get notified when there are updates to the investment portfolio of University Of Texas, based on Form 13F filings with the SEC.

Stay updated on University Of Texas with notifications on news.